Interventional technology provider C. R. Bard of Murray Hill, NJ, has posted financial results for the second quarter of 2010 (end-June 30).
For the period, net sales were $673.9 million, an increase of 8% over $624.6 million in 2009. U.S. net sales for the quarter were $464.9 million, up 7% compared to $433.6 million in the same period last year. Also in the second quarter, net income was $124.6 million, an increase of 11% compared to $112.2 million in 2009.
For the six months ended June 30, Bard's net sales were $1.3 billion, up 8% compared with $1.2 billion during the same period the previous year.
Related Reading
Bard to buy breast brachytherapy firm SenoRx, May 5, 2010
Bard posts Q4 results, January 29, 2010
Bard to launch breast tissue marker at RSNA, October 30, 2009
Philips to collaborate with Bard, January 15, 2009
Bard gets FDA nod for vascular stent, December 8, 2008
Copyright © 2010 AuntMinnie.com
